Conscience

🖥 Don't miss out on our CACHE 2 Webinar 🖥 We're 5 days away from announcing the top-scoring participants of #CACHEChallenge 2! Conscience’s webinar on September 18 at 1pm EDT will feature two of them. For this Challenge, participants were asked to identify molecules that bind to a highly conserved site on a SARS-CoV-2 protein, NSP13. If one of these molecules (or “hits”) were eventually developed into a new drug, that drug should be effective against any current or future coronaviruses, marking a significant step towards pandemic preparedness. While we can’t reveal the identities of the speakers yet, we can tell you, that they are new participants employing creative and surprising strategies including relying on AI, citizen science, and a variety of open source software packages. One of the teams predicted the highest number of hits of any team and the other was the biggest team yet. The speakers will take you through the strategy behind their approach and showcase the software tools in their method, enabling others to build on their approach and create collaborations. If you want to learn about the cutting edge of computer-aided drug design, you won’t want to miss it. Find the registration link on our website here: https://lnkd.in/gN2mt9at Thanks to Bayer, Boehringer Ingelheim, and the The Structural Genomics Consortium (SGC) for their continued support and the National Institute of Allergy and Infectious Diseases (NIAID) for sponsoring CHACHE Challenge 2! #DrugDiscovery #OpenScience #CADD

Don’t miss out! There's still time to register for our virtual information session on the Developing Medicines through Open Science program, which offers support and partnership opportunities for preclinical drug development in disease areas neglected by the pharmaceutical industry, such as orphan diseases and antimicrobial resistance. Join us on September 11 at 1pm EDT to learn more about the program and how to apply! #DrugDiscovery #OpenScience

Don’t miss out! There's still time to register for our virtual information session on the Developing Medicines through Open Science program, which offers support and partnership opportunities for preclinical drug development in disease areas neglected by the pharmaceutical industry, such as orphan diseases and antimicrobial resistance. Join us on September 11 at 1pm EDT to learn more about the program and how to apply! #DrugDiscovery #OpenScience

📣 Call for Letters of Intent! 📣 Our Developing Medicines through Open Science program is now accepting Letters of Intent (deadline: September 27), after which selected applicants will be invited to submit a full proposal. In this inaugural round of funding, we're offering a total of $5M in funding to support collaborative drug discovery in areas like orphan diseases and antimicrobial resistance. Our goals are to drive preclinical research, establish open science proof-of-concepts, and boost Canada's economic activity, particularly benefiting SMEs. 📅 Visit the Conscience website for more details (aussi en français!): https://lnkd.in/eZK8wfJU #OpenScience #DrugDiscovery #Innovation

Optimisez vos décisions en santé avec Numana !     🗓️ Rejoignez-nous le 26 septembre à 13h00 pour un webinaire exceptionnel en anglais sur "Favoriser l'accès à de l'information de qualité et améliorer la prise de décisions en matière de santé, grâce à la technologie".      Au programme, des échanges stimulants avec des experts renommés :     - Benoit Larose, Président-directeur-général de BioQuébec  - Genevieve Lavertu, Directrice, affaires gouvernementales et politiques, technologie médicale, Johnson & Johnson Canada  - Claudia Gordijo, PhD, Directrice associée, initiatives stratégiques et partenariats au Structural Genomics Consortium  - Joris van Vugt, Directeur médical principal, responsable de la mise en œuvre pour les clients externes chez Viatris  🎤 Dylan Roskams-Edris (he/him), Responsable des événements et de la formation chez Conscience, animera ce webinaire enrichissant.    Cet événement est organisé en collaboration avec nos partenaires ECHAlliance - The Global Health Connector, Gravitate Health et Conscience. Chez Numana, nous avons à cœur d'utiliser des technologies émergentes pour le bien-être de notre communauté. Notre projet de santé connectée illustre notre engagement à améliorer l'accès à des informations fiables et à optimiser les décisions en matière de soins. Ne manquez pas cette chance d'apprendre comment la technologie peut transformer les connaissances en matière de santé et d'échanger avec des leaders du secteur. Inscrivez-vous dès maintenant et rejoignez la discussion pour façonner l'avenir de la santé ! https://lnkd.in/eHSD8qvs    #SantéConnectée #TechnologieSanté #WebinaireSanté #Numana #ECHAlliance #GravitateHealth #Conscience 

Don't miss out on this interdisciplinary virtual panel, moderated by our very own Network Lead, Dylan Roskams-Edris (he/him)! #HealthcareTechnology #OpenScience #OpenAccess #DigitalHealth #HealthcareInnovation

🖥 Webinar Announcement 🖥 Conscience’s webinar on September 18 at 1pm EDT will feature two of the top-performing teams in the second #CACHEChallenge. For this Challenge, participants were asked to identify molecules that bind to a highly conserved site on a SARS-CoV-2 protein, NSP13. If one of these molecules (or “hits”) were eventually developed into a new drug,  that drug should be effective against any current or future coronaviruses, marking a significant step towards pandemic preparedness. The official announcement of the top-scoring teams won’t happen until September 10, so we can’t reveal the identities of the speakers yet. We can tell you, that they are new participants employing creative and surprising strategies including relying on AI, citizen science, and a variety of open source software packages. One of the teams predicted the highest number of hits of any team and the other was the biggest team yet. The speakers will take you through the strategy behind their approach and showcase the software tools in their method, enabling others to build on their approach and create collaborations. If you want to learn about the cutting edge of computer-aided drug design, you won’t want to miss it. Find the registration link on our website here: https://lnkd.in/gN2mt9at

For our recently announced Developing Medicines through Open Science (DMOS), we're thrilled to have partnered with the CQDM who can provide matching funds for applicants in Quebec. See below for more details and note that the application deadline differs from our regular DMOS program. #OpenScience #DrugDiscovery #CollaborativeResearch #FundingOpportunity

📣 We're #hiring! 📣 Conscience is looking for a Senior Financial Analyst to join our team. If you have a strong background in financial reporting, analysis, and operations, and want to help us bring new medicines forward for communities that would otherwise be left behind, we’d love to hear from you! This role offers the opportunity to work closely with our CFO, improve financial processes, and support groundbreaking initiatives in open drug discovery. Interested? Learn more and apply today! Learn more about Conscience at https://conscience.ca/ #JobOpportunity #FinancialAnalyst #OpenScience #DrugDiscovery

Last week we announced Developing Medicines through Open Science, Conscience's funding program to support #DrugDiscovery in areas of market failure. On September 11, 2024 at 1pm EDT we'll be hosting a virtual information session to provide an overview of DMOS, give a walk-through of the application process, and hold a Q&A session. If you're wondering whether your project is in scope, want to know more about the support the program can provide, have questions about our #OpenScience policy, or just want to learn more about how DMOS works, we strongly encourage you to register and attend. Find more information and the registration link on our website here: https://lnkd.in/gxX7_Q8H